OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis and Validation of the First Cell-Impermeable Hsp90α-Selective Inhibitors
Tyelor S. Reynolds, Brian S. J. Blagg
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 9, pp. 1250-1256
Closed Access | Times Cited: 6
Tyelor S. Reynolds, Brian S. J. Blagg
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 9, pp. 1250-1256
Closed Access | Times Cited: 6
Showing 6 citing articles:
Conformationally Restricted Grp94-Selective Inhibitors
Hao Xu, Kyler W. Pugh, Brian S. J. Blagg
ACS Omega (2025) Vol. 10, Iss. 1, pp. 449-455
Open Access | Times Cited: 2
Hao Xu, Kyler W. Pugh, Brian S. J. Blagg
ACS Omega (2025) Vol. 10, Iss. 1, pp. 449-455
Open Access | Times Cited: 2
Advances in the structures, mechanisms and targeting of molecular chaperones
Jinying Gu, Yanyi He, Chenxi He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Jinying Gu, Yanyi He, Chenxi He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Extracellular Heat Shock Protein 90 Alpha (eHsp90α)’s Role in Cancer Progression and the Development of Therapeutic Strategies
Tyelor S. Reynolds, Brian S. J. Blagg
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116736-116736
Closed Access | Times Cited: 7
Tyelor S. Reynolds, Brian S. J. Blagg
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116736-116736
Closed Access | Times Cited: 7
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
Xinqi Liang, Ruixian Chen, Chengdi Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 15968-15995
Closed Access | Times Cited: 7
Xinqi Liang, Ruixian Chen, Chengdi Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 15968-15995
Closed Access | Times Cited: 7
Investigation of the site 2 pocket of Grp94 with KUNG65 benzamide derivatives
Kyler W. Pugh, Hao Xu, Brian S. J. Blagg
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 111, pp. 129893-129893
Closed Access | Times Cited: 4
Kyler W. Pugh, Hao Xu, Brian S. J. Blagg
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 111, pp. 129893-129893
Closed Access | Times Cited: 4
Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity
Gciniwe S. Mathenjwa, Abir Chakraborty, Abantika Chakraborty, et al.
RSC Medicinal Chemistry (2024)
Open Access | Times Cited: 1
Gciniwe S. Mathenjwa, Abir Chakraborty, Abantika Chakraborty, et al.
RSC Medicinal Chemistry (2024)
Open Access | Times Cited: 1
